// App-Quantinova.ai

: Liver-Specific p38 MAPK Stimulates Hepatic Fat Accumulation and Reduces Insulin Sensitivity In Vivo

Researchers

Presenter

  • SYDNEY L. RIVERS

Principal Investigators

  • HUIQI WANG

  • LORETTA LAM

Medical Centers

  • N/A

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Metabolic syndrome

Biomarkers

  • Mitogen-activated protein kinase

  • Nucleoside diphosphate kinase A

  • p38 Mitogen-activated protein kinases

  • Insulin

Drug/Treatment

  • VLTS-934

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A